OZEMETF / FundRoundhill GLP-1 & Weight Loss ETF
Verdicts genuinely change. Free email alert the moment OZEM's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Roundhill GLP-1 & Weight Loss ETF ETF · Roundhill ETF Trust
26 holdings · as of 2026-06-30 (4.4 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 110% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT 25.86% of portfolio weight is in non-compliant holdings, over the 5% threshold.
26 holdings, 19 matched (74% of weight). Portfolio as of 2026-06-30, filed 2026-08-26. Source: SEC Form N-PORT.
1.68% of this portfolio’s income is non-permissible — weighted across holdings, computed over 62% of portfolio weight (16 of 26 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
50.5% compliant 0.0% questionable 23.5% non-compliant 26.0% unscreened
All holdings (26)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| NOVO-B.CO Novo Nordisk A/S | COMPLIANT | 12.96% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| LLY Eli Lilly & Co | COMPLIANT | 12.69% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| Mount Vernon Liquid Assets Portfolio, LLC | UNSCREENED | 9.93% | no in-house ratios for this holding |
| PFE Pfizer Inc | NON_COMPLIANT | 6.38% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| KLRA Kailera Therapeutics Inc | NON_COMPLIANT | 6.21% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| Viking Therapeutics Inc | UNSCREENED | 5.86% | no in-house ratios for this holding |
| 1093.HK CSPC Pharmaceutical Group Ltd | COMPLIANT | 5.32% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| CHGCY Chugai Pharmaceutical Co Ltd | COMPLIANT | 4.51% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| Ascletis Pharma Inc | UNSCREENED | 4.20% | no in-house ratios for this holding |
| ZEAL.CO Zealand Pharma A/S | NON_COMPLIANT | 3.92% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| AMGN Amgen Inc | COMPLIANT | 3.85% | AAOIFI24.9% Usmani59.9% Dow Jones Islamic33.6% S&P Shariah35.1% MSCI Islamic59.9% MSCI Islamic M-Series35.1% FTSE Shariah59.9% |
| AZN AstraZeneca PLC | COMPLIANT | 3.83% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| 128940.KS Hanmi Pharm Co Ltd | COMPLIANT | 3.50% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| GPCR Structure Therapeutics Inc | NON_COMPLIANT | 3.05% | AAOIFI0.2% Usmani0.4% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.4% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| RO.SW Roche Holding AG | COMPLIANT | 3.03% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| MBX Biosciences Inc | UNSCREENED | 2.80% | no in-house ratios for this holding |
| UNITED LAB | UNSCREENED | 2.63% | no in-house ratios for this holding |
| Jiangsu Hengrui Pharmaceutical | UNSCREENED | 2.58% | no in-house ratios for this holding |
| 3692.HK Hansoh Pharmaceutical Group Co | NON_COMPLIANT | 2.54% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| 1801.HK Innovent Biologics Inc | COMPLIANT | 2.36% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| GUBRA.CO Gubra A/S | COMPLIANT | 1.87% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| GILD Gilead Sciences Inc | COMPLIANT | 1.73% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| RYTM Rhythm Pharmaceuticals Inc | NON_COMPLIANT | 1.64% | AAOIFI1.8% Usmani25.1% Dow Jones Islamic2.0% S&P Shariah2.4% MSCI Islamic25.1% MSCI Islamic M-Series2.4% FTSE Shariah24.3% |
| 4507.T Shionogi & Co Ltd | NON_COMPLIANT | 1.24% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| WVE WaVe Life Sciences Ltd | NON_COMPLIANT | 0.86% | AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0% |
| First American Government Obli | UNSCREENED | 0.62% | no in-house ratios for this holding |
The published standards disagree about this fund by 25 points of portfolio weight — 53.5% of it passes S&P Shariah, 28.2% passes Usmani. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 53.5% ratios fail on 24.2% 32.4% not rated under AAOIFI
ratios pass on 28.2% ratios fail on 49.5% 32.4% not rated under Usmani
ratios pass on 49.6% ratios fail on 18.8% 41.7% not rated under Dow Jones Islamic
ratios pass on 53.5% ratios fail on 14.9% 41.7% not rated under S&P Shariah
ratios pass on 31.2% ratios fail on 46.5% 32.4% not rated under MSCI Islamic
ratios pass on 49.6% ratios fail on 18.8% 41.7% not rated under MSCI Islamic M-Series
ratios pass on 31.2% ratios fail on 46.5% 32.4% not rated under FTSE Shariah
19 of 26 listed holdings carry our own per-methodology verdicts (82% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 8 (36% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| PFE Pfizer Inc | 6.38% |
| KLRA Kailera Therapeutics Inc | 6.21% |
| ZEAL.CO Zealand Pharma A/S | 3.92% |
| GPCR Structure Therapeutics Inc | 3.05% |
| 3692.HK Hansoh Pharmaceutical Group Co | 2.54% |
| RYTM Rhythm Pharmaceuticals Inc | 1.64% |
| 4507.T Shionogi & Co Ltd | 1.24% |
| WVE WaVe Life Sciences Ltd | 0.86% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Roundhill GLP-1 & Weight Loss ETF (OZEM) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for OZEM — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 55.70 | NEUTRAL |
| Stochastic %K (14) | 75.34 | NEUTRAL |
| CCI (20) | 88.82 | NEUTRAL |
| Williams %R (14) | -24.66 | NEUTRAL |
| MACD (12,26,9) | 0.21 | BUY |
| ROC (10) | 2.90 | BUY |
| Momentum (10) | 0.88 | BUY |
| EMA (10) | 31.08 | BUY |
| SMA (10) | 31.09 | BUY |
| EMA (20) | 30.73 | BUY |
| SMA (20) | 30.41 | BUY |
| EMA (30) | 30.68 | BUY |
| SMA (30) | 30.12 | BUY |
| EMA (50) | 30.86 | BUY |
| SMA (50) | 30.68 | BUY |
| EMA (100) | 31.33 | SELL |
| SMA (100) | 31.81 | SELL |
| EMA (200) | 31.92 | SELL |
| SMA (200) | 31.91 | SELL |
About Roundhill GLP-1 & Weight Loss ETF
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 44 |
| 🕐 1H | BULLISH | 28 |
| ⏱ 15-Min | BULLISH | 113 |
| ⏲ 5-Min | BULLISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-03 · Asset managers net 928584 (+5135)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.